Open access
Oct 2026
LDL-C target achievement does not equal risk resolution after ACS: residual atherogenic and inflammatory burden despite maximal oral triple lipid therapy
Findings support moving beyond LDL-centric assessment toward particle-based phenotyping and provide a mechanistic rationale for early Lp(a)-targeted and anti-inflammatory therapeutic strategies.
K. Mahajan, N. Mahajan
· European Heart Journal · 0 citations